Skip to main content

Emma Green, John Beeler

Inivata has appointed Emma Green head of clinical development and operations and John Beeler vice president of business development. Green will be responsible for clinical development initiatives at the company's laboratories in Cambridge, UK. Beeler will direct business development-related activities, such as partnerships with diagnostic and pharmaceutical companies and academic institutions internationally. 

Green most recently was at Cell Therapy Catapult as head of clinical operations. She previously worked at Pfizer, Aventis, Sosei UK, and Serentis. Beeler was previously the director of theranostics and business development at BioMérieux, where he was responsible for companion diagnostic development and commercialization.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.